Catalyst Program

The Catalyst Program is UCSF’s translational accelerator focused on advancing UCSF discoveries with clinical impact and commercial potential through funding, mentorship, and identification of resources. The Catalyst Program aims to foster academic and industry collaborations as well as enhance education in early translational research and entrepreneurship. 

Catalyst Awards

The centerpiece of the Catalyst Program are Catalyst Awards that provide both industry advisor mentorship and seed funding to UCSF PIs with promising projects. The Catalyst Awards are an intramural funding mechanism focused on the development of therapeutics, diagnostics, medical devices and digital health products. Through funding and an advisor network of 200+ experts from academia and life sciences industry, the Catalyst Program works to commercialize the ideas of UCSF PIs and turn them into products. For additional information click here.

Click here to view the list of previous Catalyst Awardees. 

The Fall 2018 application window begins on 8/20/18 and ends at 2PM PST on 9/17/18. 

Learn More & Apply

Internship

The Catalyst Internship Program provides an opportunity to learn about early translational research and the process of translating academic discoveries into valuable products. It runs parallel to the Catalyst Awards and allows the Catalyst Interns to observe the events of the Catalyst Awards, the review process, and the unique interactions between the academic researchers and industry experts. Interns will have the opportunity to contribute to the project teams that are receiving Catalyst consultations. In addition, the interns will participate in small group discussions with Catalyst advisors on topics related to product development and careers in industry.

The internship will expose students to the industry perspective in evaluating the potential of scientific discoveries to lead to products. Students will develop appreciation for issues such as defining unmet needs, assessing commercialization potential and development feasibility for an early-stage idea, and defining key milestones on the development path. The program is of value to those interested in doing translational research, either in an academic or industry setting.

Fall 2018 Deadline: September 21, 2018

Learn More & Apply

Case Studies

Case-based teaching has been extensively used in business schools and offers an advantageous model for bridging the gap between concept and practice. To complement existing classroom training in entrepreneurship on campus, and to offer more flexible and modular learning opportunities to academic translational scientists, Catalyst program has developed a series of case studies as a part of the online educational curriculum. We identify the best representative cases (many from UCSF) aligned to the core principles of startup business, and interview the founders of these startup companies, in particular the academic innovators. These cases highlight the challenges and real-world lessons learned from academic translational research to commercially viable products.

Learn More

Catalyst + Plus

The Catalyst Program expanded to Catalyst + Plus, a new addition that aims to provide additional support to past Catalyst projects with a successful progress yet still seeking business advice and/or supplemental funding.

UC Center for Accelerated Innovation

UCCAI is a multi-campus funding mechanism for technology development in disease areas of interest to NHLBI.

Learn More

Helpful Links

             In the News                                     eNewsletter                                       

                      

 

         Seminars & Events                             Success Stories

       

 

 

 

Contact the Catalyst Program

For questions about the Catalyst Program please contact, [email protected] or one of our team members.

Sign up for the Catalyst Program eNewsletter

What We Do

  • Consultation / Mentorship
  • Translational Funding
  • Technology Development

Our Team

  • Charles Hart, PhD

    Director

    Charles Hart is the director of the Catalyst program. From 2004 to 2017 he was at Threshold Pharmaceuticals and responsible for both in vitro and in vivo preclinical translational studies. He was also project leader for the global clinical development program for the hypoxia-targeted anticancer drug evofosfamide (TH-302), a partnership with Merck KGaA. Prior to joining Threshold, Charles was Senior Director of Biology at...

    Read more
  • Michael Lesh, MD

    Executive Director, Health Technology Innovation

    Michael D. Lesh, MD is a physician, scientist and entrepreneur. He earned undergraduate and graduate degrees in Computer Science and Bioengineering from the Massachusetts Institute of Technology (MIT) before entering medical school at the University of California San Francisco (UCSF).

    ... Read more
  • Roopa Ramamoorthi, PhD

    Program Director, Devices and Therapeutics

    Roopa Ramamoorthi brings a diverse scientific background in drug development, bacteriology, biotechnology, and engineering. Prior to joining UCSF, Roopa was Associate Director Partnering and Scientific Affairs at BIO Ventures for Global Health, where her focus was putting together collaborations between academic, non profit and pharmaceutical organizations to accelerate the development of drugs, vaccines and diagnostics for Neglected...

    Read more
  • Nathaniel Prorok

    Program Coordinator

    Nathaniel Prorok brings a diverse and wide ranging skill set and experience to the Catalyst Program team. After undergraduate studies in Physical Therapy and Athletic Training at Loyola Marymount University, Nathaniel worked with the Jesuit...

    Read more